Summary slide.png (125.32 kB)

Frequency of Prescription Claims for Drugs that May Interact with Janus kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

media

posted on 2021-01-06, 16:24 authored by Alison Walton, Jim Paik, Amanda Quebe, Carol L. Kannowski, Casey Choong, Seth Anderson, Justin K. Owensby

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s40744-020-00275-8

Usage metrics

Read the peer-reviewed publication

Frequency of Prescription Claims for Drugs that May Interact with Janus kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

Rheumatology and Therapy

Keywords

Baricitinib Drug-drug interaction Janus kinase inhibitors Real-world study Rheumatoid arthritis Tofacitinib Upadacitinib

Licence

CC BY-NC 4.0

Frequency of Prescription Claims for Drugs that May Interact with Janus kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports